Skin studies in animals
Published skin and dermatology studies in dogs, cats and other animals, by any route.
This page lists published studies. It reports what the authors did and found, with the limits of each study. It is not advice.
19 studies listed, newest first.
- Palmitoylethanolamide-Incorporated Elastic Nano-Liposomes for Enhanced Transdermal Delivery and Anti-InflammationLaboratory studyHumansOther animalsTopical
- Distribution of Cannabinoid Receptors in Keratinocytes of Healthy Dogs and Dogs With Atopic DermatitisLaboratory studyDogs
- Palmitoylethanolamide and Related ALIAmides for Small Animal Health: State of the ArtReviewDogsCats
- N-Acylethanolamine acid amidase (NAAA) exacerbates psoriasis inflammation by enhancing dendritic cell (DCs) maturationLaboratory studyHumansOther animals
- Anti-inflammatory Effect of Cannabidiol and Palmitoylethanolamide Containing Topical Formulation on Skin in a 12-O-Tetradecanoylphorbol-13-Acetate-Induced Dermatitis Model in MiceLaboratory studyOther animalsTopicalWith cannabidiol
- A Glucuronic Acid-Palmitoylethanolamide Conjugate (GLUPEA) Is an Innovative Drug Delivery System and a Potential BioregulatorLaboratory studyOther animalsWith GLUPEA (a glucuronic acid-PEA conjugate prodrug, tested against ultramicronised PEA)
- Palmitoylethanolamide and Related ALIAmides: Prohomeostatic Lipid Compounds for Animal Health and WellbeingReviewDogsCatsOther animals
- Effect of Hataedock Treatment on Epidermal Structure Maintenance through Intervention in the Endocannabinoid SystemLaboratory studyOther animalsWith Douchi (fermented soybean) extract used as Hataedock; genistein and PEA compared in a separate involucrin assay
- Effect of dietary supplementation with ultramicronized palmitoylethanolamide in maintaining remission in cats with nonflea hypersensitivity dermatitis: a double-blind, multicentre, randomized, placebo-controlled studyRandomised controlled trialCats
- Ultramicronized palmitoylethanolamide counteracts the effects of compound 48/80 in a canine skin organ culture modelLaboratory studyDogs
- Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitisLaboratory studyDogsOther animals
- Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitisLaboratory studyOther animals
- Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre studyOpen-label, no control groupDogs
- Improvement of Topical Palmitoylethanolamide Anti-Inflammatory Activity by Pegylated ProdrugsLaboratory studyOther animalsTopicalWith polyethylene glycol (PEG) prodrugs of PEA, tested alone as modified forms of PEA
- Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitisLaboratory studyDogs
- Effects of palmitoylethanolamide on the cutaneous allergic inflammatory response in Ascaris hypersensitive Beagle dogsLaboratory studyDogs
- Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitisControlled trialDogsTopicalWith adelmidrol (a PEA analogue, tested alone)
- Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNF-alpha release from canine skin mast cellsLaboratory studyDogs
- Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot studyOpen-label, no control groupCats